Dupixent 300 MG/2 ML pen 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26FP8XE
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $55,433
Award facts
- Contract value 100% obligated
- $55,433.25 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
On January 26, 2026, the Defense Logistics Agency awarded a $55,433.25 delivery order to AmerisourceBergen Drug Corp for 300 mg/2 ml Dupixent pens (2 ml vials). The contract is structured as a firm fixed-price delivery order with no set-aside designation, indicating competitive award. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as the prime contractor, with parent company Cencora, Inc. (doing business as AmerisourceBergen) overseeing the corporate structure. The place of performance is located in Conshohocken, Pennsylvania, with an ultimate completion date of January 27, 2026.
This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.99 billion prime vendor agreement running through December 2026 that serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs. Dupixent is a biologic medication used for treating conditions including atopic dermatitis, asthma, and chronic rhinosinusitis with nasal polyps, and this specific task order fulfills immediate pharmaceutical supply needs for the Defense Health Agency and affiliated military medical treatment facilities.
Quick answers
Who was awarded contract SPE2DR26FP8XE?
SPE2DR26FP8XE was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 26, 2026.
How much is contract SPE2DR26FP8XE worth?
The government has obligated $55,433 on SPE2DR26FP8XE.
Is contract SPE2DR26FP8XE an order under another contract?
Yes. SPE2DR26FP8XE is a delivery order under SPE2DR25D3005, an indefinite delivery contract.
Was contract SPE2DR26FP8XE competed?
The extent of competition for SPE2DR26FP8XE was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award